Amelia Merrill - 01 Mar 2023 Form 4 Insider Report for Guardant Health, Inc. (GH)

Role
SVP, People
Signature
/s/ John Saia, as sttorney-in-fact for Amelia Merrill
Issuer symbol
GH
Transactions as of
01 Mar 2023
Net transactions value
-$1,908
Form type
4
Filing time
03 Mar 2023, 15:57:03 UTC
Previous filing
05 Dec 2022
Next filing
05 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GH COMMON STOCK Options Exercise $0 +157 +0.68% $0.000000 23,113 01 Mar 2023 Direct
transaction GH COMMON STOCK Tax liability $1,908 -65 -0.28% $29.36 23,048 01 Mar 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GH RESTRICTED STOCK UNITS Options Exercise $0 -157 -9% $0.000000 1,579 01 Mar 2023 COMMON STOCK 157 $0.000000 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability.
F2 The restricted stock unit vests as to 25% of the shares subject to such award on September 1, 2022, and the remaining 75% of the shares subject to such award in equal installments on each quarterly anniversary of of September 1, 2022, during the three-year period thereafter.
F3 Not applicable for Restricted Stock Units.

Remarks:

Table I, includes 241 shares acquired under Guardant Health's Employee Stock Purchase Plan on 5/14/2022.